Lectin binding pattern of Hodgkin disease-derived cell lines in comparison to other human cell lines. 1987

M Schwonzen, and G Uhlenbruck, and M Schaadt, and D Funken, and H Burrichter, and V Diehl
Medizinische Klinik I der Universität zu Köln, Federal Republic of Germany.

The three Hodgkin disease-derived cell lines L 428, L 540, and L 591 were characterized in their carbohydrate epitope composition by a panel of lectins. Nine other human cell lines were tested in comparison to the Hodgkin (H) and Sternberg Reed (SR) cells: promyelocytic (HL 60), lymphoblastoid, myeloma, histiocytic lymphoma (U 937), and other non-Hodgkin lymphoma cell lines. Twenty-four different fluoresceinated lectins bound to the Hodgkin and other cell lines in different percentages of positive cells and with varying intensities. Lotus lectin and a monoclonal anti-Lewis blood group X antibody showed very similar binding patterns (L 428, L 540, HL 60, U 937). Soybean agglutinin stained only L 428 and L 540, although nearly all were positive after neuraminidase treatment. Cell lysis of the three H cell lines resulted in a very similar electrophoretic mobility pattern of proteins. In addition, staining of transblotted glycoproteins with biotinylated concanavalin A by avidin peroxidase reaction revealed corresponding bands. Differences were seen with Lotus staining. In summary, the origin of H cells is still unknown, but there is obviously some relationship in the glycoconjugate profile to the myelohistiocytic lineage.

UI MeSH Term Description Entries
D011975 Receptors, Mitogen Glycoprotein molecules on the surface of B- and T-lymphocytes, that react with molecules of antilymphocyte sera, lectins, and other agents which induce blast transformation of lymphocytes. Lectin Receptors,Mitogen Receptors,Receptors, Lectin,Mitogen Receptor,Receptor, Mitogen
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002462 Cell Membrane The lipid- and protein-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells. Plasma Membrane,Cytoplasmic Membrane,Cell Membranes,Cytoplasmic Membranes,Membrane, Cell,Membrane, Cytoplasmic,Membrane, Plasma,Membranes, Cell,Membranes, Cytoplasmic,Membranes, Plasma,Plasma Membranes
D006689 Hodgkin Disease A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the classical variant, giant usually multinucleate Hodgkin's and REED-STERNBERG CELLS are present; in the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen. Granuloma, Hodgkin,Granuloma, Malignant,Hodgkin Lymphoma,Lymphogranuloma, Malignant,Granuloma, Hodgkin's,Granuloma, Hodgkins,Hodgkin Lymphoma, Adult,Hodgkin's Disease,Hodgkin's Lymphoma,Hodgkins Disease,Lymphocyte Depletion Hodgkin's Lymphoma,Lymphocyte-Rich Classical Hodgkin's Lymphoma,Mixed Cellularity Hodgkin's Lymphoma,Nodular Lymphocyte-Predominant Hodgkin's Lymphoma,Nodular Sclerosing Hodgkin's Lymphoma,Adult Hodgkin Lymphoma,Disease, Hodgkin,Disease, Hodgkin's,Disease, Hodgkins,Hodgkin Granuloma,Hodgkin's Granuloma,Hodgkins Granuloma,Hodgkins Lymphoma,Lymphocyte Rich Classical Hodgkin's Lymphoma,Lymphogranulomas, Malignant,Lymphoma, Hodgkin,Lymphoma, Hodgkin's,Malignant Granuloma,Malignant Granulomas,Malignant Lymphogranuloma,Malignant Lymphogranulomas,Nodular Lymphocyte Predominant Hodgkin's Lymphoma
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured

Related Publications

M Schwonzen, and G Uhlenbruck, and M Schaadt, and D Funken, and H Burrichter, and V Diehl
June 2001, Melanoma research,
M Schwonzen, and G Uhlenbruck, and M Schaadt, and D Funken, and H Burrichter, and V Diehl
January 1988, Anticancer research,
M Schwonzen, and G Uhlenbruck, and M Schaadt, and D Funken, and H Burrichter, and V Diehl
September 1984, Nihon Hifuka Gakkai zasshi. The Japanese journal of dermatology,
M Schwonzen, and G Uhlenbruck, and M Schaadt, and D Funken, and H Burrichter, and V Diehl
September 1984, Nihon Hifuka Gakkai zasshi. The Japanese journal of dermatology,
M Schwonzen, and G Uhlenbruck, and M Schaadt, and D Funken, and H Burrichter, and V Diehl
January 1989, Cancer treatment and research,
M Schwonzen, and G Uhlenbruck, and M Schaadt, and D Funken, and H Burrichter, and V Diehl
February 2021, Biomedicines,
M Schwonzen, and G Uhlenbruck, and M Schaadt, and D Funken, and H Burrichter, and V Diehl
July 2009, Leukemia research,
M Schwonzen, and G Uhlenbruck, and M Schaadt, and D Funken, and H Burrichter, and V Diehl
August 1992, Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft,
M Schwonzen, and G Uhlenbruck, and M Schaadt, and D Funken, and H Burrichter, and V Diehl
November 1994, The Histochemical journal,
M Schwonzen, and G Uhlenbruck, and M Schaadt, and D Funken, and H Burrichter, and V Diehl
February 1993, International journal of pancreatology : official journal of the International Association of Pancreatology,
Copied contents to your clipboard!